Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

PubMed

Regulatory approaches towards AI Medical Devices: A comparative study of the United States, the European Union and China.

PMID: 39951854 · 2025

JournalHealth policy (Amsterdam, Netherlands)
Year2025
PMID39951854

Abstract

The swift progression of AI within the realm of medical devices has precipitated an imperative for stringent regulatory oversight. The United States, the European Union, and China stand as vanguard entities in the regulatory landscape for AI-enhanced medical devices, each delineating unique regulatory frameworks. The European Union is renowned for its avant-garde approach to AI legislation, placing a significant onus on data security. Conversely, the regulatory paradigm in the United States is c

Official Source

View on PubMed →

Data sourced from PubMed / NCBI. For the full text and most current information, always refer to the official record.